Literature DB >> 3264366

Modulation of functions of granulocytes by recombinant human GM-CSF and possible complications of GM-CSF therapy.

M Klausmann1, K H Pflüger, D Krumwieh, F R Seiler, K Havemann.   

Abstract

Besides its effect on bone marrow progenitors, GM-CSF is able to modulate functions of mature cells such as neutrophils. It inhibits random migration and chemotaxis through action on both cells and chemotactic factors, and stimulates oxidative metabolism as well as elastase release. Furthermore, it strongly enhances the response of the cells to the usual stimulants such as f-Met-Leu-Phe and phorbol esters. The role of neutral proteinases and activated oxygen species in different diseases such as ARDS, emphysema, coagulation defects, arthritis, and inflammation, is recognized. The remarkable in vitro release of neutral proteinases and activated oxygen species from granulocytes after GM-CSF stimulation may be of importance in vivo. This should be considered in clinical application of GM-CSF, particularly with high-dose therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264366

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

1.  Granulocyte-macrophage colony-stimulating factor augments neutrophil killing of Torulopsis glabrata and stimulates neutrophil respiratory burst and degranulation.

Authors:  I C Kowanko; A Ferrante; D P Harvey; K L Carman
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

2.  Capillary leak syndrome during low dose granulocyte-macrophage colony-stimulating factor (rh GM-CSF) treatment of a patient in a continuous febrile state.

Authors:  W Emminger; W Emminger-Schmidmeier; C Peters; M Susani; R Hawliczek; P Höcker; H Gadner
Journal:  Blut       Date:  1990-10

Review 3.  The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary.

Authors:  G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.